TY - JOUR
T1 - ICD-11
T2 - Impact on Traditional Chinese Medicine and World Healthcare Systems
AU - Lam, Wai Ching
AU - Lyu, Aiping
AU - Bian, Zhaoxiang
N1 - Publisher copyright:
© Springer Nature Switzerland AG 2019
PY - 2019/10
Y1 - 2019/10
N2 - World Health Organization (WHO) member states adopted the eleventh revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11) on 25 May 2019. Historically, traditional Chinese medicine (TCM) was excluded from the ICD system. Including TCM in the ICD-11 is not only a landmark for the ICD but also a milestone for TCM: it enables the statistical data to cover information beyond Western medicine, thus reflecting the true situation of healthcare systems among member states of the WHO. This initiative is in line with the WHO Traditional Medicine Strategy (2014–2023), demonstrating that the WHO appreciates the past contribution of TCM to healthcare worldwide, and that it is responding to the current needs of its member states. Further, this action will have long-term impacts on TCM. It is a critical step not only because TCM may take this chance to be developed further among WHO member states, but also because TCM should benefit from improved service levels, education, research, and regulation. In addition, this initiative contributes to the progressive reform of the world healthcare system, from global extension of TCM to the integration of TCM with multiple Western medicine-based disciplines. People all over the world will benefit.
AB - World Health Organization (WHO) member states adopted the eleventh revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11) on 25 May 2019. Historically, traditional Chinese medicine (TCM) was excluded from the ICD system. Including TCM in the ICD-11 is not only a landmark for the ICD but also a milestone for TCM: it enables the statistical data to cover information beyond Western medicine, thus reflecting the true situation of healthcare systems among member states of the WHO. This initiative is in line with the WHO Traditional Medicine Strategy (2014–2023), demonstrating that the WHO appreciates the past contribution of TCM to healthcare worldwide, and that it is responding to the current needs of its member states. Further, this action will have long-term impacts on TCM. It is a critical step not only because TCM may take this chance to be developed further among WHO member states, but also because TCM should benefit from improved service levels, education, research, and regulation. In addition, this initiative contributes to the progressive reform of the world healthcare system, from global extension of TCM to the integration of TCM with multiple Western medicine-based disciplines. People all over the world will benefit.
UR - http://www.scopus.com/inward/record.url?scp=85069688931&partnerID=8YFLogxK
U2 - 10.1007/s40290-019-00295-y
DO - 10.1007/s40290-019-00295-y
M3 - Journal article
C2 - 31933225
AN - SCOPUS:85069688931
SN - 1178-2595
VL - 33
SP - 373
EP - 377
JO - Pharmaceutical Medicine
JF - Pharmaceutical Medicine
IS - 5
ER -